等待開盤 01-13 09:30:00 美东时间
+0.050
+0.32%
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
Barclays analyst Benjamin Budish maintains Blue Owl Capital (NYSE:OWL) with a Overweight and lowers the price target from $19 to $18.
01-09 22:56
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
The largest tech companies are increasingly relying on private credit to finance their AI ambitions, but is this a prelude to a bubble?
01-02 03:34
科技巨头正通过华尔街投资者资助的特殊目的实体(SPV),将超1200亿美元数据中心支出转移至表外,加剧了市场对其AI豪赌背后金融风险的担忧。
2025-12-26 20:00
①大型科技公司正通过华尔街投资者注资的特殊目的载体(SPV),将逾1200亿美元的数据中心支出移出它们的资产负债表; ②这加剧了业界对其在人工智能领域巨额押注所涉金融风险的担忧。
2025-12-26 08:48
历史数据显示,12月初疲软不影响“圣诞老人反弹”大概率出现,加上通胀降温与就业放缓为美联储降息铺路,银行股领涨显示板块轮动扩大,年末行情可期。
2025-12-22 17:08
由于全球新建数据中心对藤仓有限公司的电缆需求激增,该公司股价也随之飙升,但该公司却无法满足市场需求。
2025-12-19 08:35
由于全球新建数据中心对藤仓有限公司的电缆需求激增,该公司股价也随之飙升,但该公司却无法满足市场需求。
2025-12-19 08:35